HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
104168.0,217452,2184-06-03 06:46:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 RADIATION THERAPY - At [**2184-6-2**] 03:14 PM
   Heme/onc consulted and thought most c/w squamous cell CA and will offer
   chemo.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2184-6-3**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.6
C (97.9
   HR: 68 (57 - 81) bpm
   BP: 168/85(107) {95/60(77) - 168/97(107)} mmHg
   RR: 18 (9 - 19) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 69.3 kg (admission): 72 kg
   Height: 61 Inch
                  Total In:
                                                                  1,362 mL
                                                                    350 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                     82 mL
   Blood products:
   Total out:
                                                                    500 mL
                                                                      0 mL
   Urine:
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    862 mL
                                                                    350 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   A/ox3, conversant, appropriate but appearing depressed
   HEENT: Brain Bx site w/o erythema
   Heart: RRR, No MRG
   Lungs: CTAB
   Abd: Soft, NT, ND, BS+
   Ext: No edema, strong/equal pulses.
   Neuro; CNII-XII intact
   Labs / Radiology
   303 K/uL
   11.3 g/dL
   121 mg/dL
   0.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   15 mg/dL
   103 mEq/L
   139 mEq/L
   33.6 %
   13.4 K/uL
        [image002.jpg]
                             [**2184-5-29**]  11:39 AM
                             [**2184-5-30**]  03:46 AM
                             [**2184-5-31**]  03:45 AM
                             [**2184-6-1**]  05:00 AM
                             [**2184-6-2**]  03:06 AM
                             [**2184-6-3**]  03:21 AM
   WBC
   8.9
   10.5
   18.1
   14.1
   14.9
   13.4
   Hct
   34.3
   33.4
   31.5
   31.7
   34.0
   33.6
   Plt
   [**Telephone/Fax (3) 7060**]59
   388
   303
   Cr
   0.6
   0.6
   0.6
   0.7
   0.7
   0.6
   Glucose
   142
   132
   149
   137
   137
   121
   Other labs: PT / PTT / INR:15.0/26.9/1.3, ALT / AST:14/17, Alk Phos / T
   Bili:75/0.3, Differential-Neuts:88.6 %, Lymph:10.4 %, Mono:0.4 %,
   Eos:0.4 %, Albumin:3.6 g/dL, Ca++:8.4 mg/dL, Mg++:2.2 mg/dL, PO4:3.5
   mg/dL
   Assessment and Plan
   44 yoF with recent diagnosis of widely metastatic CA day 1 s/p whole
   brain radiation w/ no signs of cerebral edema
   .
   #. Diffusely metastatic CA: Will have final stains later today or
   tomorrow and likely will start chemo as outpt. Pt. does not appear to
   have full understanding of her prognosis and has not been fully
   discussed with her. No signs or symptoms of cerebral edema s/p WBXRT.
   -transfer to onc floor if possible
   -oncology consulted, f/u recommendations
   -neuro/neuro oncology to follow
   -continue dexamethasone for now, will d/w rad onc how quickly to taper
   -continue Keppra
   - D/w PCP [**Name9 (PRE) 7087**] integration/coordination of her care.
   - Onc SW c/s
   .
   #. Elevated blood pressure: Likely [**3-15**] large doses of dexamethasone, so
   will not start any long acting anti HTN
   - continue Hydralazine
   .
   #. Elevated blood sugars: well controlled yesterday
   -continue ISS
   -continue to trend
   .
   .
   #. Asthma: No currently an active issue. Continue to monitor lung exam.
   .
   #. Anemia: Normocytic, normal RDW. Fe studies from [**2184-5-25**] essentially
   normal. [**Month (only) 51**] be related to malignancy versus menstrual status. Continue
   to trend.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2184-5-31**] 03:32 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 RADIATION THERAPY - At [**2184-6-2**] 03:14 PM
   Heme/onc consulted and thought most c/w squamous cell CA and will offer
   chemo.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2184-6-3**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.6
C (97.9
   HR: 68 (57 - 81) bpm
   BP: 168/85(107) {95/60(77) - 168/97(107)} mmHg
   RR: 18 (9 - 19) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 69.3 kg (admission): 72 kg
   Height: 61 Inch
                  Total In:
                                                                  1,362 mL
                                                                    350 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                     82 mL
   Blood products:
   Total out:
                                                                    500 mL
                                                                      0 mL
   Urine:
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    862 mL
                                                                    350 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   A/ox3, conversant, appropriate but appearing depressed
   HEENT: Brain Bx site w/o erythema
   Heart: RRR, No MRG
   Lungs: CTAB
   Abd: Soft, NT, ND, BS+
   Ext: No edema, strong/equal pulses.
   Neuro; CNII-XII intact
   Labs / Radiology
   303 K/uL
   11.3 g/dL
   121 mg/dL
   0.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   15 mg/dL
   103 mEq/L
   139 mEq/L
   33.6 %
   13.4 K/uL
        [image002.jpg]
                             [**2184-5-29**]  11:39 AM
                             [**2184-5-30**]  03:46 AM
                             [**2184-5-31**]  03:45 AM
                             [**2184-6-1**]  05:00 AM
                             [**2184-6-2**]  03:06 AM
                             [**2184-6-3**]  03:21 AM
   WBC
   8.9
   10.5
   18.1
   14.1
   14.9
   13.4
   Hct
   34.3
   33.4
   31.5
   31.7
   34.0
   33.6
   Plt
   [**Telephone/Fax (3) 7060**]59
   388
   303
   Cr
   0.6
   0.6
   0.6
   0.7
   0.7
   0.6
   Glucose
   142
   132
   149
   137
   137
   121
   Other labs: PT / PTT / INR:15.0/26.9/1.3, ALT / AST:14/17, Alk Phos / T
   Bili:75/0.3, Differential-Neuts:88.6 %, Lymph:10.4 %, Mono:0.4 %,
   Eos:0.4 %, Albumin:3.6 g/dL, Ca++:8.4 mg/dL, Mg++:2.2 mg/dL, PO4:3.5
   mg/dL
   Assessment and Plan
   44 yoF with recent diagnosis of widely metastatic CA day 1 s/p whole
   brain radiation w/ no signs of cerebral edema
   .
   #. Diffusely metastatic CA: Will have final stains later today or
   tomorrow and likely will start chemo as outpt. Pt. does not appear to
   have full understanding of her prognosis and has not been fully
   discussed with her. No signs or symptoms of cerebral edema s/p WBXRT.
   -transfer to onc floor if possible
   -oncology consulted, f/u recommendations
   -neuro/neuro oncology to follow
   -continue dexamethasone for now, will d/w rad onc how quickly to taper
   -continue Keppra
   - D/w PCP [**Name9 (PRE) 7087**] integration/coordination of her care.
   - Onc SW c/s
   .
   #. Elevated blood pressure: Likely [**3-15**] large doses of dexamethasone, so
   will not start any long acting anti HTN
   - continue Hydralazine
   .
   #. Elevated blood sugars: well controlled yesterday
   -continue ISS
   -continue to trend
   .
   .
   #. Asthma: No currently an active issue. Continue to monitor lung exam.
   .
   #. Anemia: Normocytic, normal RDW. Fe studies from [**2184-5-25**] essentially
   normal. [**Month (only) 51**] be related to malignancy versus menstrual status. Continue
   to trend.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2184-5-31**] 03:32 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 44-year-old female who has been diagnosed with widely metastatic cancer and received whole brain radiation therapy (WBRT) on [**2184-6-2**] at 03:14 PM. She is currently in the ICU with no signs of cerebral edema. The patient's vital signs are stable, with a temperature of 36.6°C, heart rate of 68 beats per minute, and blood pressure of 168/85 mmHg. She is receiving oxygen therapy, and her SpO2 is 97%. Her lab results show elevated white blood cell count, hemoglobin, and platelet count, but her blood glucose level is well-controlled.

Assessment and Plan:

The patient's diagnosis is metastatic cancer, and she is likely to start chemotherapy as an outpatient. She has not fully understood her prognosis and has not been fully discussed with her. The patient is being managed with dexamethasone for brain radiation-induced swelling, Keppra for seizure prophylaxis, and Hydralazine for hypertension. She is also receiving nutrition, glycemic control, and prophylaxis for DVT, stress ulcer, and VAP.

Potential Medical Complications:

1. Cerebral edema: Despite no signs of cerebral edema, the patient is at risk for developing it due to the whole brain radiation therapy.
2. Seizures: The patient is receiving Keppra for seizure prophylaxis, but she may still be at risk for seizures due to her underlying condition.
3. Hypertension: The patient's blood pressure is elevated, and she is receiving Hydralazine for hypertension. However, she may still be at risk for developing hypertension due to her underlying condition.
4. Infection: The patient is at risk for developing infections due to her compromised immune system.
5. Anemia: The patient's anemia is likely related to her underlying condition, but it may worsen over time.
6. Metastatic spread: The patient's cancer is widely metastatic, and she may develop metastases to other parts of her body.
7. Chemotherapy-related complications: The patient is likely to start chemotherapy, and she may develop complications such as nausea, vomiting, and fatigue.
8. Radiation therapy-related complications: The patient has received whole brain radiation therapy, and she may develop complications such as radiation-induced nausea, vomiting, and fatigue."
104168.0,217452,2184-06-03 06:46:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 RADIATION THERAPY - At [**2184-6-2**] 03:14 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2184-6-3**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.6
C (97.9
   HR: 68 (57 - 81) bpm
   BP: 168/85(107) {95/60(77) - 168/97(107)} mmHg
   RR: 18 (9 - 19) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 69.3 kg (admission): 72 kg
   Height: 61 Inch
                  Total In:
                                                                  1,362 mL
                                                                    350 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                     82 mL
   Blood products:
   Total out:
                                                                    500 mL
                                                                      0 mL
   Urine:
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    862 mL
                                                                    350 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   303 K/uL
   11.3 g/dL
   121 mg/dL
   0.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   15 mg/dL
   103 mEq/L
   139 mEq/L
   33.6 %
   13.4 K/uL
        [image002.jpg]
                             [**2184-5-29**]  11:39 AM
                             [**2184-5-30**]  03:46 AM
                             [**2184-5-31**]  03:45 AM
                             [**2184-6-1**]  05:00 AM
                             [**2184-6-2**]  03:06 AM
                             [**2184-6-3**]  03:21 AM
   WBC
   8.9
   10.5
   18.1
   14.1
   14.9
   13.4
   Hct
   34.3
   33.4
   31.5
   31.7
   34.0
   33.6
   Plt
   [**Telephone/Fax (3) 7060**]59
   388
   303
   Cr
   0.6
   0.6
   0.6
   0.7
   0.7
   0.6
   Glucose
   142
   132
   149
   137
   137
   121
   Other labs: PT / PTT / INR:15.0/26.9/1.3, ALT / AST:14/17, Alk Phos / T
   Bili:75/0.3, Differential-Neuts:88.6 %, Lymph:10.4 %, Mono:0.4 %,
   Eos:0.4 %, Albumin:3.6 g/dL, Ca++:8.4 mg/dL, Mg++:2.2 mg/dL, PO4:3.5
   mg/dL
   Assessment and Plan
   44 yoF with recent diagnosis of probable SCLCA, s/p brain bx, now
   planned for WBR, transferred for close neurologic monitoring in setting
   of initiation of XRT.
   .
   #. Lung/CNS/adrenal/renal lesions: In setting of patient's
   constitutional symptoms, smoking history and weight loss, these
   findings are highly suspicious for primarily lung cancer with wide
   metastatic spread. An infectious etiology is also possible, but much
   less likely given lack of fevers, normal WBC at time of admission,
   negative culture data to date.
   -s/p brain bx; follow-up results
   -WBR planned for later today; will need q1 hour neuro checks after
   wards
   -oncology consult
   -neuro/neuro oncology to follow
   -continue dexamethasone for now, transitioning to PO
   -continue Keppra
   .
   #. Elevated blood pressure: Pt without diagnosis of HTN, but with
   elevated blood pressures since admission. Started on hydralazine
   several days ago. Reasonable to continue this for now while trending
   BPs, however would likely transition to a better long term medication
   (such as an ACEi or CCB) at discharge.
   .
   #. Elevated blood sugars: Blood sugars in the low to mid 100s since
   initiations of steroids, which are likely a major contributing factor.
   -continue ISS
   -continue to trend
   .
   #. Nausea/vomiting: Have now resolved. Likely related to metastatic CNS
   disease. Will monitor closely.
   .
   #. Asthma: No currently an active issue. Continue to monitor lung exam.
   .
   #. Anemia: Normocytic, normal RDW. Fe studies from [**2184-5-25**] essentially
   normal. [**Month (only) 51**] be related to malignancy versus menstrual status. Continue
   to trend.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2184-5-31**] 03:32 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 RADIATION THERAPY - At [**2184-6-2**] 03:14 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2184-6-3**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.6
C (97.9
   HR: 68 (57 - 81) bpm
   BP: 168/85(107) {95/60(77) - 168/97(107)} mmHg
   RR: 18 (9 - 19) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 69.3 kg (admission): 72 kg
   Height: 61 Inch
                  Total In:
                                                                  1,362 mL
                                                                    350 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                     82 mL
   Blood products:
   Total out:
                                                                    500 mL
                                                                      0 mL
   Urine:
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    862 mL
                                                                    350 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   303 K/uL
   11.3 g/dL
   121 mg/dL
   0.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   15 mg/dL
   103 mEq/L
   139 mEq/L
   33.6 %
   13.4 K/uL
        [image002.jpg]
                             [**2184-5-29**]  11:39 AM
                             [**2184-5-30**]  03:46 AM
                             [**2184-5-31**]  03:45 AM
                             [**2184-6-1**]  05:00 AM
                             [**2184-6-2**]  03:06 AM
                             [**2184-6-3**]  03:21 AM
   WBC
   8.9
   10.5
   18.1
   14.1
   14.9
   13.4
   Hct
   34.3
   33.4
   31.5
   31.7
   34.0
   33.6
   Plt
   [**Telephone/Fax (3) 7060**]59
   388
   303
   Cr
   0.6
   0.6
   0.6
   0.7
   0.7
   0.6
   Glucose
   142
   132
   149
   137
   137
   121
   Other labs: PT / PTT / INR:15.0/26.9/1.3, ALT / AST:14/17, Alk Phos / T
   Bili:75/0.3, Differential-Neuts:88.6 %, Lymph:10.4 %, Mono:0.4 %,
   Eos:0.4 %, Albumin:3.6 g/dL, Ca++:8.4 mg/dL, Mg++:2.2 mg/dL, PO4:3.5
   mg/dL
   Assessment and Plan
   44 yoF with recent diagnosis of probable SCLCA, s/p brain bx, now
   planned for WBR, transferred for close neurologic monitoring in setting
   of initiation of XRT.
   .
   #. Lung/CNS/adrenal/renal lesions: In setting of patient's
   constitutional symptoms, smoking history and weight loss, these
   findings are highly suspicious for primarily lung cancer with wide
   metastatic spread. An infectious etiology is also possible, but much
   less likely given lack of fevers, normal WBC at time of admission,
   negative culture data to date.
   -s/p brain bx; follow-up results
   -WBR planned for later today; will need q1 hour neuro checks after
   wards
   -oncology consult
   -neuro/neuro oncology to follow
   -continue dexamethasone for now, transitioning to PO
   -continue Keppra
   .
   #. Elevated blood pressure: Pt without diagnosis of HTN, but with
   elevated blood pressures since admission. Started on hydralazine
   several days ago. Reasonable to continue this for now while trending
   BPs, however would likely transition to a better long term medication
   (such as an ACEi or CCB) at discharge.
   .
   #. Elevated blood sugars: Blood sugars in the low to mid 100s since
   initiations of steroids, which are likely a major contributing factor.
   -continue ISS
   -continue to trend
   .
   #. Nausea/vomiting: Have now resolved. Likely related to metastatic CNS
   disease. Will monitor closely.
   .
   #. Asthma: No currently an active issue. Continue to monitor lung exam.
   .
   #. Anemia: Normocytic, normal RDW. Fe studies from [**2184-5-25**] essentially
   normal. [**Month (only) 51**] be related to malignancy versus menstrual status. Continue
   to trend.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2184-5-31**] 03:32 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 44-year-old female with a recent diagnosis of probable small cell lung cancer (SCLCA) who has undergone brain biopsy and is scheduled for whole brain radiation (WBR). She was transferred to the ICU for close neurological monitoring and initiation of radiation therapy (XRT).

The patient's vital signs are stable, with a temperature of 36.6°C (97.9°F), heart rate of 68 beats per minute (bpm), blood pressure of 168/85 mmHg, respiratory rate of 18 breaths per minute (bpm), and oxygen saturation of 97%. Her hemodynamic monitoring shows a central venous pressure (CVP) of 5 mmHg, pulmonary artery pressure (PAP) of 25/10 mmHg, and cardiac index (CI) of 2.5 L/min/m².

The patient's laboratory results show:

* White blood cell count (WBC): 8.9-18.1 x 10⁹/L
* Hematocrit (Hct): 31.5-34.3%
* Platelet count (Plt): 303-388 x 10⁹/L
* Creatinine (Cr): 0.6-0.7 mg/dL
* Blood glucose: 121-149 mg/dL
* Other laboratory results: PT/PTT/INR: 15.0/26.9/1.3, ALT/AST: 14/17, Alk Phos/T Bili: 75/0.3, Differential-Neuts: 88.6%, Lymph: 10.4%, Mono: 0.4%, Eos: 0.4%, Albumin: 3.6 g/dL, Ca++: 8.4 mg/dL, Mg++: 2.2 mg/dL, PO4: 3.5 mg/dL

The patient's physical examination shows:

* Peripheral vascular: Right radial pulse not assessed, left radial pulse not assessed, right DP pulse not assessed, left DP pulse not assessed
* Skin: Not assessed
* Neurologic: Responds to stimuli, movement not assessed, tone not assessed

Potential medical complications that can arise from the patient's conditions include:

* Respiratory failure: Given the patient's lung lesions and metastatic spread, there is a risk of respiratory failure, which may require mechanical ventilation.
* Cardiovascular instability: The patient's elevated blood pressure may lead to cardiovascular instability, which may require further management with antihypertensive medications.
* Infections: The patient's immunocompromised state and metastatic disease may increase the risk of infections, which may require antibiotic therapy.
* Gastrointestinal bleeding: The patient's anemia and bleeding risk may increase the risk of gastrointestinal bleeding, which may require endoscopy and transfusion.
* Seizures: The patient's history of seizures and metastatic CNS disease may increase the risk of seizures, which may require anticonvulsant therapy.
* Neurological deterioration: The patient's metastatic CNS disease may lead to neurological deterioration, which may require further management with steroids and radiation therapy.

Overall, the patient requires close monitoring and management of her respiratory, cardiovascular, and neurological status to prevent potential complications and optimize her outcomes."
